My cart
In the shopping cart is not goods, to choose and buy!
  • Product Name
  • Size
  • Quantity
  • Amount
    Selected items : 0 pieces Total : CHECK OUT()
    ABT-737
    ABT-737

    Price：
    Market Price：

    This product is for research use only, not for human use. We do not sell to patients.
    Number： - + Pieces（InventoryPieces）
    InvivoChem Cat #: V0002
    CAS #: 852808-04-9Purity ≥98%

    Description: ABT-737 is a novel, potent,  selective and orally available BH3 mimetic inhibitor of Bcl-xL, Bcl-2 and Bcl-w with EC50 of 78.7 nM, 30.3 nM and 197.8 nM in enzymatic assays, respectively. It does not inhibit Mcl-1, Bcl-B or Bfl-1 etc. It is currently in Phase 2 clinical trial for cancer treatment. ABT-737 has shown single-agent activity against lymphoma and small-cell lung cancer as well as substantial antimyeloma activity both in vitro and in vivo. The mechanism of action of ABT-737 is to mimic BH3 (the native ligand of BCL-2) and act as a BCL-2 inhibitor. It blocks the anti-apoptotic BCL-2 protein, leading to programmed cell death of CLL cells.

    References: Cancer Res. 2007 Feb 1;67(3):1176-83.; Cell Death Differ. 2013 Jan;20(1):57-63. 


    Customer Validation
    Official Supplier of
    • VE
    • OF
    • YALE
    • hhmi
    • 香港大学
    Related Products
    Publications Citing InvivoChem Products
    • Citation of InvivoChem BMS-582949 (V2668)
    • Citation of InvivoChem Resveratrol (V0430)
    • Citation of InvivoChem venetoclax and S63845
    • Citation of InvivoChem KD025 (SLx-2119)
    • Citation of InvivoChem Tubastatin A HCl
    • Citation of InvivoChem BMS-1166
    • Physicochemical and Storage Information
    • Protocol
    • Quality Control Documentation
    • Related Biological Data
    • Customer Review
    Molecular Weight (MW)813.43
    FormulaC42H45ClN6O5S2
    CAS No.852808-04-9
    Storage-20℃ for 3 years in powder form
    -80℃ for 2 years in solvent
    Solubility (In vitro)DMSO:    100 mg/mL (122.93 mM)
    Water:     <1 mg/mL (slightly soluble or insoluble)
    Ethanol:  <1 mg/mL
    Solubility (In vivo)30% Propylene glycol, 5% Tween 80, 65% D5W: 30mg/mL
    SMILES CodeO=C(NS(=O)(C1=CC=C(N[[email protected]](CCN(C)C)CSC2=CC=CC=C2)C([N+]([O-])=O)=C1)=O) C3=CC=C(N4CCN(CC5=CC=CC=C5C6=CC=C(Cl)C=C6) CC4)C=C3
    Chemical Name(R)-4-(4-((4'-chloro-[1,1'-biphenyl]-2-yl)methyl)piperazin-1-yl)-N-((4-((4-(dimethylamino)-1-(phenylthio)butan-2-yl)amino)-3-nitrophenyl)sulfonyl)benzamide
    SynonymsABT 737; ABT-737; ABT737
    • Molarity Calculator
    • Dilution Calculator
    • The molarity calculator equation

      Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

      • Mass
      • Concentration
      • Volume
      • Molecular Weight *
      • =
      • ×
      • ×
    • The dilution calculator equation

      Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

      This equation is commonly abbreviated as: C1V1 = C2V2

      • Concentration (start)
      • ×
      • Volume (start)
      • =
      • Concentration (final)
      • ×
      • Volume (final)
      • ×
      • =
      • ×
      • C1
      •  
      • V1
      •  
      • C2
      •  
      • V2
    GeneralIn aggressive leukemia model, ABT-737 suppresses the leukemia burden by 53% at 30 mg/kg and extended survival of mice.
    Animal modelScid mice injected with Luc-expressing FD/ΔRaf-1:ER cells
    Formulation1 g/mL stock solution of ABT-737 in DMSO is added to a mixture of 30% propylene glycol, 5% Tween 80, 65% D5W (5% dextrose in water) (pH 4−5; final concentration of DMSO ≤ 1%)
    Dosages20 and 30 mg/kg
    AdministrationFor intraperitoneal (i.p.) every day
    References 2006 Nov;10(5):375-88.

    These protocols are for reference only. InvivoChem does not independently validate these methods.

    ABT-737

    Whole cell lysates of Mel-RM and MM200 cells were subjected to Western blot analysis following treatment with ABT-737 (10µM) for indicated periods. Data are representative of three individual experiments.

    ABT-737

    As an inhibitor of Bcl-2, ABT-737 is effective to reduce cell viability in HG3-CLL cells. Incubating the cells with ABT-737 in 96 well plates (3×104 cells per well) for 24h shows a dose-dependent inhibition of cell viability with EC50 value of 500nM.

    ABT-737

    评论

      Home Prev Next Last page / pices

      发评论

      ×
      Your information is safe with us. * Required Fields.
      Products are for research use only;  We do not sell to patients
      Contact Us
      Contact Us
      Tel: 1-708-310-1919
      Fax: 1-708-557-7486
      Email: [email protected]
      Frequently Asked Questions
      Subscribe to our E-newsletter
      • Name*
      • *
      • E-mail*
      • *
      • instructions：
      • *
      Copyright 2020 InvivoChem LLC | All Rights Reserved
        Site map
      prompt
      Do you confirm the receipt?